和铂医药(02142.HK) 公布,于上周五(7日)于公开市场购回价值近1,000万元的股份,创下联交所上市生物科技公司于2025年的单日购回记录。
于2023及2024年,公司已合共购回587万股股份,所有该等股份已由公司注销,将有助于提升余下股东的整体价值。公司正加强对股东价值最大化的承诺。(jl/w)(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.